302P Clinical benefit of adding pertuzumab in neoadjuvant HER2-positive breast cancer: Response and 5-year survival outcomes
2025 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2025.08.731
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
10
Papers
5
Citations
2
h-index
0
i10-index
A. Pous Badía is an academic researcher from Institut Català d'Oncologia. The author has contributed to research in topics: Head and Neck Cancer Studies & Breast Cancer Treatment Studies & Nutrition and Health in Aging. The author has an h-index of 2, co-authored 9 publications.
Click to start Chat